ScoreWhy is Fuan Pharmaceutical (Group) Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.09%
- The company has been able to generate a Return on Capital Employed (avg) of 2.09% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -7.24% and Operating profit at -42.42% over the last 5 years
3
The company has declared negative results for the last 2 consecutive quarters
- NET PROFIT(HY) At CNY 96.84 MM has Grown at -45.93%
- INTEREST(HY) At CNY 15.18 MM has Grown at 41.07%
- PRE-TAX PROFIT(Q) At CNY 7.98 MM has Fallen at -73.72%
4
Below par performance in long term as well as near term
- Along with generating -10.31% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fuan Pharmaceutical (Group) Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Fuan Pharmaceutical (Group) Co., Ltd.
-10.31%
0.27
29.31%
China Shanghai Composite
16.01%
1.07
14.99%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.24%
EBIT Growth (5y)
-42.42%
EBIT to Interest (avg)
-1.18
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.45
Tax Ratio
10.56%
Dividend Payout Ratio
21.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.09%
ROE (avg)
4.59%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.15
EV to EBIT
33.78
EV to EBITDA
16.99
EV to Capital Employed
1.15
EV to Sales
2.54
PEG Ratio
NA
Dividend Yield
1.63%
ROCE (Latest)
3.40%
ROE (Latest)
5.79%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
CASH AND EQV(HY)
Highest at CNY 2,049.06 MM
-35What is not working for the Company
NET PROFIT(HY)
At CNY 96.84 MM has Grown at -45.93%
INTEREST(HY)
At CNY 15.18 MM has Grown at 41.07%
PRE-TAX PROFIT(Q)
At CNY 7.98 MM has Fallen at -73.72%
OPERATING CASH FLOW(Y)
Lowest at CNY 187.49 MM
ROCE(HY)
Lowest at 3.26%
RAW MATERIAL COST(Y)
Grown by 27.84% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.46 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.49 times
NET SALES(Q)
Lowest at CNY 394.87 MM
OPERATING PROFIT(Q)
Lowest at CNY -2.87 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -0.73 %
Here's what is working for Fuan Pharmaceutical (Group) Co., Ltd.
Cash and Eqv
Highest at CNY 2,049.06 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Fuan Pharmaceutical (Group) Co., Ltd.
Net Profit
At CNY 96.84 MM has Grown at -45.93%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 15.18 MM has Grown at 41.07%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Pre-Tax Profit
At CNY 7.98 MM has Fallen at -73.72%
over average net sales of the previous four periods of CNY 30.38 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Sales
At CNY 394.87 MM has Fallen at -15.65%
over average net sales of the previous four periods of CNY 468.11 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 187.49 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 394.87 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -2.87 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -0.73 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 1.46 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 5.49 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 27.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 2.08 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
